Tuttiquotidiani e completamente gratuito. Ogni giorno aggreghiamo notizie da oltre 100 testate e generiamo sintesi AI originali per te. Aiutaci a mantenere il servizio attivo con una piccola donazione, oppure diventa TQ Pro da solo 1€/mese.

Fai una donazione TQ Pro - 1€/mese
  1. Home

Exclusive | Pfizer, Amgen among 22 strategic firms eyeing Hong Kong expansion: source

  • Posted on April 20, 2026
  • By South China Morning Post
  • 0 Views
  • 1 min read
In brief

Hong Kong continues strengthening its position as a global biotech and innovation hub through its latest investment drive. A sixth cohort of 22 prominent multinational corporations, including pharmaceutical giants Pfizer and Amgen, has committed to expanding operations in the territory. The initiative also encompasses biotech firms like Boehringer Ingelheim and Hengrui, alongside emerging players in mobility solutions such as DiDi and AutoFlight, signaling diversified growth across multiple strategic sectors.

Exclusive | Pfizer, Amgen among 22 strategic firms eyeing Hong Kong expansion: source
Exclusive | Pfizer, Amgen among 22 strategic firms eyeing Hong Kong expansion: source

Sixth batch under investment-attraction initiative to also feature Boehringer Ingelheim, Hengrui and HAYA, with DiDi and AutoFlight joining transport push.
continue reading...

Author
South China Morning Post

You May Also Like